Intrua Financial, LLC Abbott Laboratories Transaction History

Intrua Financial, LLC

$829 Million
Q3 2025

A detailed history of Intrua Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Intrua Financial, LLC holds 13,364 shares of ABT stock, worth $1.74 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

13,364

Previous 12,289 8.75%

Holding current value

$1.74 Million

Previous $1.67 Million 7.06%

% of portfolio

0.22%

Previous 0.25%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	BUY	$120.51 - $136.62 $129,548 - $146,866	1,075 Added 8.75%	13,364 $1.79 Million
Q2 2025 Aug 08, 2025	BUY	$123.95 - $138.08 $295,744 - $329,458	2,386 Added 24.09%	12,289 $1.67 Million
Q1 2025 May 28, 2025	SELL	$111.1 - $140.22 $6,221 - $7,852	-56 Reduced 0.56%	9,903 $1.31 Million
Q4 2024 May 28, 2025	SELL	$111.93 - $119.39 $387,949 - $413,805	-3,466 Reduced 25.82%	9,959 $1.13 Million
Q3 2024 May 28, 2025	SELL	$100.07 - $118.13 $88,762 - $104,781	-887 Reduced 6.2%	13,425 $1.53 Million

Q2 2024 May 28, 2025	SELL	$100.73 - $112.44 $27,398 - $30,583	-272 Reduced 1.87%	14,312 $1.49 Million
Q1 2024 May 28, 2025	SELL	$109.52 - $120.96 $8,104 - $8,951	-74 Reduced 0.5%	14,584 $1.66 Million
Q4 2023 May 28, 2025	SELL	$90.19 - $110.4 $43,742 - $53,544	-485 Reduced 3.2%	14,658 $1.61 Million
Q3 2023 May 28, 2025	SELL	$95.53 - $114.62 $34,390 - $41,263	-360 Reduced 2.32%	15,143 $1.47 Million
Q2 2023 Feb 13, 2025	BUY	$100.78 - $112.29 $744,361 - $829,373	7,386 Added 90.99%	15,503 $1.69 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $37,484 - $44,121	-387 Reduced 4.55%	8,117 $821,000
Q4 2022 Jan 20, 2023	BUY	$95.06 - $111.52 $170,062 - $199,509	1,789 Added 26.64%	8,504 $0
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $6,289 - $7,281	65 Added 0.98%	6,715 $650,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $38,072 - $46,017	-373 Reduced 5.31%	6,650 $723,000
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $505,564 - $616,503	4,434 Added 171.26%	7,023 $831,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $19,986 - $24,472	-173 Reduced 6.26%	2,589 $364,000
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $78,978 - $87,373	677 Added 32.47%	2,762 $353,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $3,491 - $4,109	-33 Reduced 1.56%	2,085 $253,000
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $30,475 - $35,904	280 Added 15.23%	2,118 $258,000
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $74,503 - $90,478	-813 Reduced 30.67%	1,838 $207,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $202,987 - $259,798	2,651 New	2,651 $268,000

Others Institutions Holding ABT

# of Institutions

3,651

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrua Financial, LLC with notifications on news.

Account

Intrua Financial, LLC Abbott Laboratories Transaction History